Clinical trials recruiting for Stage II Pancreatic Cancer AJCC v8
9
Recruiting trials
51
US states with sites
2
Countries
0%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Oregon | 5 |
| California | 3 |
| Connecticut | 3 |
| Florida | 3 |
| Georgia | 3 |
| Illinois | 3 |
| Arizona | 2 |
| Arkansas | 2 |
| Colorado | 2 |
| Delaware | 2 |
| District of Columbia | 2 |
| Hawaii | 2 |
Top cities
Portland, Oregon 5Atlanta, Georgia 3Chicago, Illinois 3New Haven, Connecticut 3Ann Arbor, Michigan 2Baltimore, Maryland 2Bismarck, North Dakota 2Buffalo, New York 2Charleston, South Carolina 2Cincinnati, Ohio 2
Self-screener
Recruiting trials
- A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
- A Tailored, Web-based Program (COMPASS) to Improve Exercise and Dietary Changes in Stage I-III Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy
- AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer
- CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
- Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer
- OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
- Targeted Pathway Inhibition in Patients With Pancreatic Cancer
- Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors
- Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Related conditions
Trials recruiting for Stage II Pancreatic Cancer AJCC v8 often also study these conditions. Each links to its own recruiting-trial list.
Stage III Pancreatic Cancer AJCC v8 14Pancreatic cancer 870Stage IV Pancreatic Cancer AJCC v8 19Metastatic Pancreatic Carcinoma 8Borderline Resectable Pancreatic Ductal Adenocarcinoma 7Stage I Pancreatic Cancer AJCC v8 5Metastatic Pancreatic Ductal Adenocarcinoma 12Locally Advanced Pancreatic Ductal Adenocarcinoma 8Advanced Pancreatic Carcinoma 5Advanced Malignant Solid Neoplasm 13
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Stage II Pancreatic Cancer AJCC v8 trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.